Research of the EML4-ALK Gene Expression in the Pleural Effusion or Tumor Tissue From Lung Cancer Patients

NCT01257308 | Unknown

• 1 other identifier: 99047
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

We wants to analyse the EML4-ALK mutation rate in the patients who have non-small cell lung cancer.

Conditions

Lung Cancer Patients

Keywords

lung cancer

Eligibility Criteria

• Age: 20 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Lung Cancer Patients

You may qualify if:

• or more than 20 years of age
• The pathological diagnosis confirmed lung cancer
• Patients have achieved pleural effusion, or surgical biopsy to obtain tumor tissue specimens
• The patient had signed inform consent

You may not qualify if:

• pleural effusion or tumor tissue can not be obtained
• the patient is not suitable to join the research according to the judgement by the investigator

Sponsors & Collaborators

• Taipei Medical University WanFang Hospital: lead

Study Sites (1)

Taipei Medical University - WanFang Hospital

Taipei, Taiwan

Location

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Hsin-Gjin Eugene Liu

  Taipei Medical University WanFang Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: December 8, 2010
• First Posted: December 9, 2010
• Study Start: August 1, 2010
• Study Completion: August 1, 2013
• Last Updated: December 9, 2010

Record last verified: 2010-12

Locations

TW (1)